Search global stocks & ETFs...Ctrl K
Learn Mode
Intuitive Surgical IncISRG
$353.33
$0.36 (0.102%)
$353.32
-$0.008 (-0.002%)
ISRG
Stock Profile
10-19
Recommended Metric
Score Card
Explore Scores Tab
4.07
Good
Valuation Score
Key Score
4.00
Good
Management
3.00
Average
Growth
1.00
Very Bad
Profitability
3.00
Average
Fin. Health
1.00
Very Bad
Dividends
--
--
Analyst
3.00
Average
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending Jun 28, 2027
Current
$353.33
Baseline
High
$787.50
▲
122.88%
Avg
$582.34
▲
64.81%
Low
$369.66
▲
4.62%
Analyst Ratings based on 40 Analysts
Strong Buy
1128%
Buy
1743%
Hold
1128%
Sell
103%
Strong Sell
000%
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.Read More